Advisory Services Network’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.58K Buy
+1,000
New +$3.97K ﹤0.01% 3976
2025
Q4
Sell
-1,000
Closed -$3.26K 3703
2025
Q3
$3.26K Buy
+1,000
New +$3.15K ﹤0.01% 3668
2024
Q1
Sell
-1,000
Closed -$30K 3161
2023
Q4
$30K Buy
+1,000
New +$22.1K ﹤0.01% 2299
2023
Q2
Sell
-1,000
Closed -$17.1K 3144
2023
Q1
$17.1K Hold
1,000
﹤0.01% 2638
2022
Q4
$19.6K Buy
+1,000
New +$18.4K ﹤0.01% 2492

Other funds holding RCKT

Advisory Services Network's RCKT Position: Q1 2026 in Review

Advisory Services Network opened a new position in Rocket Pharmaceuticals (RCKT) in Q1 2026: 1,000 shares worth $3.58K. The stake represents ﹤0.01% of the portfolio and ranks #3976 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in RCKT as recently as Q3 2025.

Advisory Services Network first reported a position in RCKT in Q4 2022 and has held it in 5 quarters since. The position peaked at $30K in Q4 2023. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Advisory Services Network held 1,000 shares of Rocket Pharmaceuticals worth $3.58K as of Q1 2026.
  • Rocket Pharmaceuticals was a new Advisory Services Network position in Q1 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3976 holding.
  • Advisory Services Network first reported a position in Rocket Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
  • Advisory Services Network's Rocket Pharmaceuticals position peaked at $30K in Q4 2023.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.